PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

QQQ $ 451.64 $ 2.72 (0.61 %)

DIA $ 398.72 $ 0.84 (0.21 %)

SPY $ 528.64 $ 2.73 (0.52 %)

TLT $ 92.21 $ 0.37 (0.4 %)

GLD $ 221.06 $ 1.82 (0.83 %)

Previous Close

$ 2.23

Open

$ 2.40

Bid

$ 2.13 x 1,200

Ask

$ 2.14 x 380

Day's Range

$ 2.04 - $ 2.46

52 Week Range

$ 1.25 - $ 14.55

Volume

26,365,041

Average Volume

Market Cap

601.16M

Beta (5Y Monthly)

$ 2.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-28-2024	12-31-2023	10-K
3	11-03-2023	09-30-2023	10-Q
4	08-04-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	02-28-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-06-2021	03-31-2021	10-Q
14	02-26-2021	12-31-2020	10-K
15	11-03-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-08-2020	03-31-2020	10-Q
18	02-28-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-06-2019	06-30-2019	10-Q
21	05-03-2019	03-31-2019	10-Q
22	02-26-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-03-2018	06-30-2018	10-Q
25	05-02-2018	03-31-2018	10-Q
26	02-26-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-02-2017	06-30-2017	10-Q
29	05-05-2017	03-31-2017	10-Q
30	03-06-2017	12-31-2016	10-K
31	11-04-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	03-11-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-05-2015	06-30-2015	10-Q
37	05-05-2015	03-31-2015	10-Q
38	03-12-2015	12-31-2014	10-K
39	11-05-2014	09-30-2014	10-Q
40	08-05-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Morgan Stanley Maintains Equal-Weight on P...
05/15/2024 14:28:07

Morgan Stanley analyst Tejas Savant maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price tar...

Ambry Genetics And PacBio Selected By UCI ...
05/15/2024 13:49:08

Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:P...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 16:31:13

sony-group-posts-upbeat-earnings-joins-gamestop-paysafe-and-other-big-stocks-moving-higher-on-tuesday

Sony Group Posts Upbeat Earnings, Joins Ga...
05/14/2024 15:01:34

Expert Outlook: Pacific Biosciences Throug...
05/13/2024 18:00:48

Piper Sandler Maintains Neutral on Pacific...
05/13/2024 12:57:50

Piper Sandler analyst David Westenberg maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and lowers the price targe...

Barclays Maintains Equal-Weight on Pacific...
05/10/2024 19:13:36

Barclays analyst Luke Sergott maintains Pacific Biosciences (NASDAQ:PACB) with a Equal-Weight and lowers the price target fr...

PacBio Expects To Reduce Non-GAAP Annualiz...
05/09/2024 20:26:11

Initiated activities to reduce annualized run-rate operating expenses and the Company expects to achieve above the high end of ...

Pacific Biosciences Q1 2024 Adj EPS $(0.26...
05/09/2024 20:08:44

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $...

why-perficient-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-in-mondays-mid-day-session

Why Perficient Shares Are Trading Higher B...
05/06/2024 16:32:34

Tesla, Deciphera Pharmaceuticals, Heartlan...
04/29/2024 14:47:40

skechers-reports-upbeat-earnings-joins-tutor-perini-appfolio-newell-brands-and-other-big-stocks-moving-higher-on-friday

Skechers Reports Upbeat Earnings, Joins Tu...
04/26/2024 14:45:17

JP Morgan Downgrades Pacific Biosciences t...
04/22/2024 12:20:48

JP Morgan analyst Rachel Vatnsdal downgrades Pacific Biosciences (NASDAQ:PACB) from Overweight to Neutral.

Goldman Sachs Maintains Neutral on Pacific...
04/19/2024 14:38:36

Goldman Sachs analyst Matthew Sykes maintains Pacific Biosciences (NASDAQ:PACB) with a Neutral and lowers the price target f...

Bernstein Maintains Outperform on Pacific ...
04/18/2024 16:56:16

Bernstein analyst Eve Burstein maintains Pacific Biosciences (NASDAQ:PACB) with a Outperform and lowers the price target fro...

Goldman Sachs Downgrades Pacific Bioscienc...
04/18/2024 14:32:28

Goldman Sachs analyst Matthew Sykes downgrades Pacific Biosciences (NASDAQ:PACB) from Buy to Neutral and lowers the price ta...

Scotiabank Maintains Sector Outperform on ...
04/18/2024 11:22:12

Scotiabank analyst Sung Ji Nam maintains Pacific Biosciences (NASDAQ:PACB) with a Sector Outperform and lowers the price tar...

A Glimpse Into The Expert Outlook On Pacif...
04/17/2024 20:00:50

TD Cowen Maintains Buy on Pacific Bioscien...
04/17/2024 15:09:17

TD Cowen analyst Daniel Brennan maintains Pacific Biosciences (NASDAQ:PACB) with a Buy and lowers the price target from $12 ...

why-invo-bioscience-shares-are-trading-higher-by-around-73-here-are-20-stocks-moving-premarket

Why INVO Bioscience Shares Are Trading Hig...
04/17/2024 10:13:57

Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.